Clinical trial
Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small…
NCT00495170 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00495170 |
|---|---|
| Title | Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) |
| Official title | Phase II Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Carboplatin, Proton Radiotherapy, Paclitaxel |
| Enrollment | 84 |
| Start date | Apr 14, 2006 |
| Primary completion | Jun 14, 2017 |
| Completion | Jun 14, 2017 |
| First posted | Jul 2, 2007 |
| Last update posted | Feb 6, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: